The Patent Finder
US

Stable Aqueous Formulations of Adalimumab

US 9,346,880 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed May 24, 2024 on the fee record · Medium confidence

Why Medium: A terminal disclaimer is on file (approved) with no resolved reference, so the term may end earlier.

Second maintenance fee unpaid; grace period ended.

Filed Mar 18, 2015 as application 14/661,899 · Granted May 24, 2016
Base term, 20 years from filing
Today
Lapsed May 24, 2024
2013 2033
Clock starts
Sep 6, 2013
No longer in force
May 24, 2024
Granted
May 24, 2016
Term would have run to
Sep 6, 2033
base term after the term ends fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
39
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Sep 6, 2033: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Sep 6, 2013, when application 14/020,733, the earliest non-provisional in its chain, was filed (this one was filed Mar 18, 2015)Sep 6, 2033High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidlapsed May 24, 2024High confidence
Computed term endThe steps above, in orderMay 24, 2024Medium confidence

This family

Application 14/020,733Abandoned
not computed
not computed
US 9,340,611Lapsed on the fee record
May 2024
May 2024
US 9,340,612Lapsed on the fee record
May 2024
May 2024
US 9,782,479Lapsed on the fee record
Oct 2025
Oct 2025
US 9,346,880this patent
May 2024
May 2024
US 9,382,317Lapsed on the fee record
Jul 2024
Jul 2024
US 9,724,414Lapsed on the fee record
Aug 2025
Aug 2025
US 9,808,525Lapsed on the fee record
Nov 2025
Nov 2025
8 of 39 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 7, 2016
Reel 37428, frame 498
Manning, Mark; Payne, RobertCoherus Biosciences, Inc.Assignment of Assignor's Interest
Jan 7, 2019
Reel 48021, frame 975
Coherus Biosciences, Inc.; Coherus Intermediate Corp.; Intekrin Therapeutics Inc.HCR Collateral Management, LLC, as Administrative AgentSecurity Interest
Jan 11, 2022
Reel 58692, frame 665
HCR Collateral Management, LLCCoherus Biosciences, Inc.; Coherus Intermediate Corp.; Intekrin Therapeutics Inc.Release of Notice of Grant of Security Interest in Patents at Reel/Frame No. 048021/0975
Jan 11, 2022
reel/frame not recorded
HCR Collateral Management, LLCCoherus Biosciences, Inc.Release of Notice of Grant of Security Interest in Patents at Reel/Frame No. 048021/0975
Jan 11, 2022
reel/frame not recorded
HCR Collateral Management, LLCCoherus Intermediate Corp.Release of Notice of Grant of Security Interest in Patents at Reel/Frame No. 048021/0975
Jan 11, 2022
reel/frame not recorded
HCR Collateral Management, LLCIntekrin Therapeutics Inc.Release of Notice of Grant of Security Interest in Patents at Reel/Frame No. 048021/0975
Mar 18, 2022
Reel 59436, frame 55
Coherus Biosciences, Inc.; Coherus Intermediate Corp.; Intekrin Therapeutics Inc.Biopharma Credit PLCSecurity Interest
May 8, 2024
Reel 67348, frame 160
Coherus Biosciences, Inc.; Coherus Intermediate Corp.; Intekrin Therapeutics Inc.; Surface Oncology, LLC; Coherus Oncology Supportive Care LLCAnkura Trust Company, LLCSecurity Interest
May 9, 2024
Reel 67378, frame 256
Biopharma Credit PLC, as Collateral AgentCoherus Biosciences, Inc.; Coherus Intermediate Corp.; Intekrin Therapeutics Inc.Termination and Release of Security Interest in Intellectual Property at Reel/Frame No. 59436/0055
May 9, 2024
reel/frame not recorded
Biopharma Credit PLC, as Collateral AgentCoherus Biosciences, Inc.Termination and Release of Security Interest in Intellectual Property at Reel/Frame No. 59436/0055
May 9, 2024
reel/frame not recorded
Biopharma Credit PLC, as Collateral AgentCoherus Intermediate Corp.Termination and Release of Security Interest in Intellectual Property at Reel/Frame No. 59436/0055
May 9, 2024
reel/frame not recorded
Biopharma Credit PLC, as Collateral AgentIntekrin Therapeutics Inc.Termination and Release of Security Interest in Intellectual Property at Reel/Frame No. 59436/0055
Aug 14, 2026
Reel 76509, frame 590
Ankura Trust Company, LLC, as Collateral AgentCoherus Oncology, Inc. (F/K/A Coherus Biosciences, Inc.); Coherus Intermediate Corp.; Intekrin Therapeutics Inc.; Surface Oncology, LLC; Coherus Oncology Supportive Care LLCRelease of Security Interest in Intellectual Property at Reel/Frame No. 67348/0160

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited